Prostatype Genomics appointed Eligen Diagnostica Sociedad Limitada and BioPortugal Quimico Farmacêutica Lda. to distribute the Prostatype ® Prostate gene test in Spain and Portugal. In line with the company strategy to pinpoint leading distributors with the ability to work with complex and innovative healthcare solutions, Prostatype Genomics is now entering a collaboration with Eligen Diagnostica and BioPortugal, leading distributors of advanced healthcare solutions in Spain and Portugal. Eligen and BioPortugal will market and distribute the Prostatype® gene test, improving the assessment quality of prostate cancer patients and opening up two new and exciting markets for Prostatype Genomics. This agreement represents a breakthrough in the commercialization efforts for Prostatype®.